RenovoRx, Inc. Increase (Decrease) in Accounts and Notes Receivable
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsAndNotesReceivable · last filed 2026-08-13
- RenovoRx, Inc. increase (decrease) in accounts and notes receivable for the quarter ending 2026-06-30 was $200.00K, a 65.29% increase year-over-year.
- RenovoRx, Inc. increase (decrease) in accounts and notes receivable for the quarter ending 2026-03-31 was $141.00K, a 29.15% decline year-over-year.
- RenovoRx, Inc. increase (decrease) in accounts and notes receivable for the quarter ending 2025-06-30 was $121.00K.
- RenovoRx, Inc. increase (decrease) in accounts and notes receivable for the quarter ending 2025-03-31 was $199.00K.
- RenovoRx, Inc. increase (decrease) in accounts and notes receivable for fiscal 2025 was $96.00K.
- RenovoRx, Inc. increase (decrease) in accounts and notes receivable for fiscal 2024 was $0.00.
| Period end | Increase (Decrease) in Accounts and Notes Receivable 3 month | Increase (Decrease) in Accounts and Notes Receivable 6 month | Increase (Decrease) in Accounts and Notes Receivable 12 month |
|---|---|---|---|
| 2026-06-30 | $200.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $341.00K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $141.00K 10-Q · filed 2026-05-14 | ||
| 2025-12-31 | $96.00K 10-K · filed 2026-03-30 | ||
| 2025-06-30 | $121.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $320.00K 10-Q · filed 2026-08-13 | |
| 2025-03-31 | $199.00K 10-Q · filed 2026-05-14 | ||
| 2024-12-31 | $0.00 10-K · filed 2026-03-30 |